Merck gets bridge finance injection for $17bn Sigma-Aldrich acquisition
Merck KGaA, the pharmaceuticals company based in Darmstadt, has obtained bridge financing for its $17bn (€13bn) acquisition of Sigma-Aldrich. The final funding structure comprises cash and debt only: around €2bn of cash on Merck’s balance sheet, €4bn of bank loans and €7bn of bonds.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
